Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Bellicum Pharmaceuticals (BLCM)

Bellicum Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLCM
DateTimeSourceHeadlineSymbolCompany
23/02/202418:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:17Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
14/02/202423:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLCMBellicum Pharmaceuticals Inc
14/02/202419:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLCMBellicum Pharmaceuticals Inc
30/01/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLCMBellicum Pharmaceuticals Inc
24/01/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLCMBellicum Pharmaceuticals Inc
30/05/202321:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/05/202321:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLCMBellicum Pharmaceuticals Inc
05/05/202321:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/04/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
31/03/202321:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
14/03/202320:30GlobeNewswire Inc.Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic AlternativesNASDAQ:BLCMBellicum Pharmaceuticals Inc
16/02/202312:30GlobeNewswire Inc.Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers SymposiumNASDAQ:BLCMBellicum Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:BLCM

Your Recent History

Delayed Upgrade Clock